secwatch.observer — SEC 8-K summary
======================================

Issuer:     Wellgistics Health, Inc. (WGRX)
CIK:        0002030763
Form:       8-K
Filed at:   2026-05-19T21:11:19+00:00
Accession:  0001493152-26-024454
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Wellgistics Q1 revenue $0.93M, net loss $7.7M; terminates Neuritek/WellCare LOIs; guides Q2 ~$1.78M
--------------------------------------------------------------------------------

- Revenue $0.93M in Q1 2026 vs $0.49M Q4 2025; expects Q2 rev $1.78M (with $0.86M recognized through May 18).
- Net operating loss $7.74M vs $32.43M prior year; EPS -$0.07 vs -$0.62 on 104.6M shares.
- Wellgistics Pharmacy monthly rev grew from ~$0.1M (Nov 2025) to ~$0.6M (Apr 2026).
- Terminated non-binding LOIs with Neuritek and WellCare; advanced discussions with Datavault AI for HaaS expansion.
- Partnership with Tollo Health and NFL Alumni Health; Health Lives Here app launch targeted Aug 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2030763/000149315226024454/0001493152-26-024454-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2030763/000149315226024454/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-024454

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer